Merck KGaA - SIC # 8090 -

Ticker Exchange SIC # Website Latest Ticker
MKKGY Over the counter 8090 www.merckgroup.com/en

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Merck KGaA

Is Merck KGaA (MKKGY) Stock Undervalued Right Now? - Nov 27th, 2024 2:40 pm
Merck KGaA Third Quarter 2024 Earnings: Misses Expectations - Nov 16th, 2024 6:59 am
Merck KGaA (MKGAF) Q3 2024 Earnings Call Highlights: Strong Organic Growth Amid Currency Headwinds - Nov 15th, 2024 7:05 am
Is Merck KGaA (MKKGY) a Great Value Stock Right Now? - Nov 11th, 2024 2:40 pm
Merck KGaA Shares Jump on Expectations of AI Boost - Oct 17th, 2024 9:40 am
Merck opens new SOD facility in South Korea - Oct 14th, 2024 8:48 am
Merck unveils $318m biosafety testing facility in Maryland, US - Oct 10th, 2024 2:26 pm
MilliporeSigma invests $290m in biosafety facility in Maryland - Oct 10th, 2024 9:20 am
Merck KGaA's (ETR:MRK) earnings growth rate lags the 11% CAGR delivered to shareholders - Sep 27th, 2024 4:31 am
Merck KGaA doses first subject in Phase III generalised Myasthenia Gravis trial - Aug 30th, 2024 10:32 am
Merck’s MilliporeSigma agrees to acquire Mirus Bio for $600m - Aug 22nd, 2024 10:53 am
Merck KGaA (MKGAF): Morgan Stanley is Bullish on This European AI Stock Now - Aug 16th, 2024 12:39 pm
Merck KGaA Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS In Line - Aug 3rd, 2024 8:05 am
Merck buys Mirus Bio to boost viral vector bioprocessing capacity - Aug 2nd, 2024 8:32 am
Merck and GTRI to develop gene therapy for Parkinson’s disease - Jul 24th, 2024 8:32 am
ASNA and Athinia® collaborate to boost semiconductor manufacturing yields through improved data sharing and traceability of subcomponent parts - Jul 8th, 2024 12:15 pm
Merck KGaA to advance mRNA vaccine platform with Afrigen - Jul 4th, 2024 8:32 am
Merck KGaA abandons Phase III trial for $1.08bn head & neck cancer drug - Jun 25th, 2024 2:14 pm
Merck KGgA shares slide after failure of potential head and neck cancer drug - Jun 25th, 2024 5:22 am
Merck KGaA's (ETR:MRK) Stock Has Fared Decently: Is the Market Following Strong Financials? - Jun 23rd, 2024 7:18 am